Boehringer Announces Major Sponsorship and Empowers Awareness of IPF
Yesterday marked a truly remarkable day in my journey as a patient living with a debilitating lung disease and the recipient of a life-saving double lung transplant. I had the incredible opportunity to share my story, "IPF to Transplant," with the esteemed employees of Boehringer at their national conference in Hobart. The chance to raise awareness about this insidious disease and shed light on the challenges faced by those affected is a rarity in the public forum in Australia. However, thanks to Boehringer's unwavering support, I was able to do just that.
As I concluded my presentation, I was presented a 'cheque' representing Boehringer's generous sponsorship of $15,000 in support of The Long Kayak for Lungs. I am beyond grateful and find it difficult to express the depth of my appreciation to Boehringer for their immense contribution. This sponsorship serves as an extraordinary platform to propel the next 42 days of awareness and fundraising efforts for The Common Good.
Boehringer's commitment to the cause of IPF and lung health is truly commendable. By stepping forward as a major sponsor, they are making a significant difference in the lives of countless individuals affected by this debilitating lung disease. Their support not only provides hope but also empowers us to continue our journey towards finding better treatments.
I would like to extend my heartfelt gratitude to Boehringer for their unwavering dedication and belief in our cause. Together, we are making strides in raising awareness, fostering understanding, and improving the lives of those impacted by IPF. This significant sponsorship ignites a flame of hope that will guide us through the upcoming 42 days of heightened awareness and fundraising efforts.
Thank you, Boehringer, for standing by us and being a beacon of support in our fight against IPF. Your contribution will undoubtedly have a lasting impact on the lives of individuals and families affected by this relentless lung disease.